U.S. License Holder:
Date of License:
NUTROPIN (somatropin) is indicated for the treatment of:
Growth Hormone Deficiency (GHD);
Growth Failure Secondary to Chronic Kidney Disease (CKD);
Idiopathic Short Stature (ISS);
Short Stature Associated with Turner Syndrome (TS);
For the replacement of endogenous GH in adults with GHD who meet eitherof the following two criteria: Adult Onset: Patients who have GHD, either alone or associated with multiple hormone deficiencies (hypopituitarism), as a result of pituitary disease, hypothalamic disease, surgery, radiation therapy, or trauma; or Childhood Onset: Patients who were GH deficient during childhood as a result of congenital, genetic, acquired, or idiopathic causes.